Morgan Stanley’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$790K Sell
69,463
-7,141
-9% -$81.2K ﹤0.01% 5229
2025
Q1
$768K Buy
76,604
+53,968
+238% +$541K ﹤0.01% 5124
2024
Q4
$402K Sell
22,636
-1,592
-7% -$28.2K ﹤0.01% 5510
2024
Q3
$496K Buy
+24,228
New +$496K ﹤0.01% 5412